mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.25 |
0.0005 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.2 |
0.001 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.001 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |